These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 1722395

  • 1. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.
    Oikawa T, Hasegawa M, Shimamura M, Ashino H, Murota S, Morita I.
    Biochem Biophys Res Commun; 1991 Dec 31; 181(3):1070-6. PubMed ID: 1722395
    [Abstract] [Full Text] [Related]

  • 2. Possible functional groups responsible for inhibition of in vivo angiogenesis by herbimycin A.
    Oikawa T, Ogasawara H, Sano H, Shibata K, Omura S.
    Biol Pharm Bull; 1994 Oct 31; 17(10):1430-2. PubMed ID: 7533023
    [Abstract] [Full Text] [Related]

  • 3. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.
    Oikawa T, Sasaki M, Inose M, Shimamura M, Kuboki H, Hirano S, Kumagai H, Ishizuka M, Takeuchi T.
    Anticancer Res; 1997 Oct 31; 17(3C):1881-6. PubMed ID: 9216639
    [Abstract] [Full Text] [Related]

  • 4. Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells.
    Oikawa T, Hasegawa M, Morita I, Murota S, Ashino H, Shimamura M, Kiue A, Hamanaka R, Kuwano M, Ishizuka M.
    Anticancer Drugs; 1992 Jun 31; 3(3):293-9. PubMed ID: 1381973
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M, Hazato T, Ashino H, Yamamoto Y, Iwasaki E, Tobe H, Yamamoto K, Yamamoto S.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):220-4. PubMed ID: 11708802
    [Abstract] [Full Text] [Related]

  • 6. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis.
    Oikawa T, Ito H, Ashino H, Toi M, Tominaga T, Morita I, Murota S.
    Eur J Pharmacol; 1993 Sep 14; 241(2-3):221-7. PubMed ID: 7694864
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    BenEzra D.
    Invest Ophthalmol Vis Sci; 1997 Nov 14; 38(12):2433-4. PubMed ID: 9375559
    [No Abstract] [Full Text] [Related]

  • 8. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R, Del Bianchi S, Soldani P, Campagni A, La Rocca RV, Myers CE, Paparelli A, Del Tacca M.
    Br J Cancer; 1993 Nov 14; 68(5):932-8. PubMed ID: 7692920
    [Abstract] [Full Text] [Related]

  • 9. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
    Sheu JR, Fu CC, Tsai ML, Chung WJ.
    Anticancer Res; 1998 Nov 14; 18(6A):4435-41. PubMed ID: 9891506
    [Abstract] [Full Text] [Related]

  • 10. Anti-angiogenic activity of triterpene acids.
    Sohn KH, Lee HY, Chung HY, Young HS, Yi SY, Kim KW.
    Cancer Lett; 1995 Aug 01; 94(2):213-8. PubMed ID: 7543366
    [Abstract] [Full Text] [Related]

  • 11. Eponemycin analogues: syntheses and use as probes of angiogenesis.
    Sin N, Meng L, Auth H, Crews CM.
    Bioorg Med Chem; 1998 Aug 01; 6(8):1209-17. PubMed ID: 9784862
    [Abstract] [Full Text] [Related]

  • 12. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M, Nagasawa H, Ashino H, Yamamoto Y, Hazato T, Uto Y, Hori H, Inayama S.
    Br J Cancer; 2003 Jan 27; 88(2):307-13. PubMed ID: 12610518
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups.
    Onozawa C, Shimamura M, Iwasaki S, Oikawa T.
    Jpn J Cancer Res; 1997 Dec 27; 88(12):1125-9. PubMed ID: 9473728
    [Abstract] [Full Text] [Related]

  • 14. Potent inhibition of angiogenesis by wortmannin, a fungal metabolite.
    Oikawa T, Shimamura M.
    Eur J Pharmacol; 1996 Dec 27; 318(1):93-6. PubMed ID: 9007518
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR, Yen MH, Kan YC, Hung WC, Chang PT, Luk HN.
    Biochim Biophys Acta; 1997 Oct 20; 1336(3):445-54. PubMed ID: 9367172
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
    Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B.
    Invest Ophthalmol Vis Sci; 1997 Apr 20; 38(5):817-23. PubMed ID: 9112976
    [Abstract] [Full Text] [Related]

  • 17. DNA chip analysis of comprehensive food function: inhibition of angiogenesis and telomerase activity with unsaturated vitamin E, tocotrienol.
    Nakagawa K, Eitsuka T, Inokuchi H, Miyazawa T.
    Biofactors; 2004 Apr 20; 21(1-4):5-10. PubMed ID: 15630161
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.
    Oikawa T, Ashino H, Shimamura M, Hasegawa M, Morita I, Murota S, Ishizuka M, Takeuchi T.
    J Antibiot (Tokyo); 1993 May 20; 46(5):785-90. PubMed ID: 7685752
    [Abstract] [Full Text] [Related]

  • 19. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
    Abe M, Inoue D, Matsunaga K, Ohizumi Y, Ueda H, Asano T, Murakami M, Sato Y.
    J Cell Physiol; 2002 Jan 20; 190(1):109-16. PubMed ID: 11807817
    [Abstract] [Full Text] [Related]

  • 20. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
    Favot L, Keravis T, Holl V, Le Bec A, Lugnier C.
    Thromb Haemost; 2003 Aug 20; 90(2):334-43. PubMed ID: 12888882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.